Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 24.38%2.77B | 30.90%1.69B | 11.17%655.72M | -35.98%3.04B | -45.87%2.23B | -61.09%1.29B | -70.51%589.81M | 9.49%4.75B | 59.89%4.12B | 129.36%3.33B |
| Refunds of taxes and levies | -26.99%168.24M | -23.83%104.93M | 22.63%63.03M | -27.62%283.43M | -36.10%230.45M | -53.52%137.76M | -71.91%51.4M | -6.88%391.59M | 62.09%360.66M | 179.77%296.38M |
| Cash received relating to other operating activities | 33.79%104.17M | 26.57%82.55M | 121.92%63.77M | 144.91%137.75M | 146.73%77.86M | 143.87%65.22M | 725.55%28.74M | 209.94%56.25M | 76.48%31.56M | 197.97%26.75M |
| Cash inflows from operating activities | 20.01%3.05B | 25.67%1.88B | 16.80%782.51M | -33.40%3.46B | -43.75%2.54B | -58.97%1.5B | -69.36%669.94M | 8.81%5.2B | 60.17%4.51B | 133.16%3.65B |
| Goods services cash paid | 72.10%2.02B | 133.92%1.41B | 102.53%534.22M | -50.74%1.8B | -62.65%1.17B | -75.54%602.07M | -80.53%263.77M | 6.53%3.65B | 66.58%3.14B | 176.79%2.46B |
| Staff behalf paid | 24.49%691.12M | 13.33%441.77M | 61.94%223.21M | 42.15%733.66M | 44.58%555.15M | 62.20%389.81M | 11.13%137.83M | 94.45%516.11M | 135.02%383.97M | 140.53%240.33M |
| All taxes paid | 164.80%120.37M | 42.78%49.37M | 18.93%26.47M | -82.40%56.83M | -85.45%45.46M | -84.15%34.58M | -77.43%22.26M | 222.61%322.85M | 1,119.48%312.48M | 1,037.89%218.16M |
| Cash paid relating to other operating activities | 52.85%119.65M | 46.94%70.64M | 42.06%29.03M | 66.79%117.29M | 33.67%78.28M | 50.63%48.08M | 58.57%20.44M | -16.86%70.32M | 33.03%58.56M | 79.68%31.92M |
| Cash outflows from operating activities | 59.29%2.95B | 83.35%1.97B | 82.97%812.93M | -40.65%2.71B | -52.46%1.85B | -63.60%1.07B | -72.06%444.3M | 17.62%4.56B | 83.90%3.9B | 187.67%2.95B |
| Net cash flows from operating activities | -85.90%96.86M | -120.73%-87.74M | -113.48%-30.42M | 18.77%753.73M | 11.26%686.82M | -39.43%423.3M | -62.12%225.65M | -29.25%634.59M | -11.72%617.3M | 29.51%698.88M |
| Investing cash flow | ||||||||||
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | ---- | ---- | 213.65%72.54K | ---- | ---- | ---- | 128.19%23.13K | 128.19%23.13K | 90.70%19.33K |
| Cash received relating to other investing activities | --35.36M | --35.36M | --35.36M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | --35.36M | --35.36M | --35.36M | 213.65%72.54K | ---- | ---- | ---- | -99.83%23.13K | 128.19%23.13K | 90.70%19.33K |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 45.56%338.15M | 47.17%222.33M | 109.27%122.42M | 13.78%408.92M | -8.59%232.31M | 22.69%151.08M | -28.35%58.5M | 44.50%359.38M | 61.25%254.14M | 109.37%123.13M |
| Cash paid to acquire investments | ---- | ---- | ---- | --200M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | 45.56%338.15M | 47.17%222.33M | 109.27%122.42M | 69.44%608.92M | -8.59%232.31M | 22.69%151.08M | -28.35%58.5M | 36.36%359.38M | 48.11%254.14M | 109.37%123.13M |
| Net cash flows from investing activities | -30.34%-302.79M | -23.76%-186.97M | -48.82%-87.06M | -69.43%-608.85M | 8.58%-232.31M | -22.71%-151.08M | 28.33%-58.5M | -43.81%-359.36M | -48.11%-254.12M | -109.37%-123.12M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.02B | ---- | ---- |
| Cash from borrowing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -82.04%25M | -82.04%25M | -82.04%25M |
| Cash inflows from financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 815.66%2.04B | -88.80%25M | -88.80%25M |
| Borrowing repayment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -52.35%94M | -52.35%94M | -34.21%94M |
| Dividend interest payment | ---- | ---- | ---- | 17,784.50%150M | ---- | ---- | ---- | -84.12%838.71K | -83.65%856.67K | -77.27%856.67K |
| Cash payments relating to other financing activities | -8.35%20.94M | -28.67%11.88M | -29.20%6.89M | -23.21%36.25M | 71.32%22.85M | 99.31%16.66M | 133.83%9.74M | 387.50%47.21M | 91.17%13.34M | 126.12%8.36M |
| Cash outflows from financing activities | -8.35%20.94M | -28.67%11.88M | -29.20%6.89M | 31.12%186.25M | -78.88%22.85M | -83.86%16.66M | -67.42%9.74M | -33.07%142.05M | -48.35%108.2M | -31.35%103.22M |
| Net cash flows from financing activities | 8.35%-20.94M | 28.67%-11.88M | 29.20%-6.89M | -109.79%-186.25M | 72.53%-22.85M | 78.70%-16.66M | -99.53%-9.74M | 17,091.86%1.9B | -702.20%-83.2M | -207.34%-78.22M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 303.98%71.41M | 2,240.28%70.64M | 246.10%31.39M | -106.51%-4.46M | -64.03%17.68M | -95.99%3.02M | -468.41%-21.48M | 160.93%68.42M | 1,399.74%49.14M | 983.41%75.33M |
| Net increase in cash and cash equivalents | -134.60%-155.46M | -183.52%-215.96M | -168.40%-92.98M | -102.04%-45.82M | 36.52%449.33M | -54.86%258.59M | -73.61%135.93M | 228.24%2.25B | -38.79%329.14M | 5.08%572.88M |
| Add:Begin period cash and cash equivalents | -1.51%2.99B | -1.51%2.99B | -1.51%2.99B | 283.88%3.04B | 283.88%3.04B | 283.88%3.04B | 283.88%3.04B | 639.84%791.33M | 639.84%791.33M | 639.84%791.33M |
| End period cash equivalent | -18.66%2.84B | -15.79%2.78B | -8.66%2.9B | -1.51%2.99B | 211.21%3.49B | 141.63%3.3B | 142.93%3.17B | 283.88%3.04B | 73.80%1.12B | 109.19%1.36B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.